Organization (Hospital)
Ochsner Health System
ClinicalTrials.gov lists Ochsner Health System as lead sponsor of 57 trials. It has 25 active development programs and 20 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 4 registered with a 2026 start date. The dashed outline is the pace from the 4 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 4.0 trial starts a year over the five years to September, under the 5 a year the method needs. 2 trials are registered to start in 2027 or later.
This page covers Ochsner Health System: 57 lead-sponsored trials and 1 legal-entity registration.
Disease areas (128)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Pain | 9 |
| Hypertension | 4 |
| Obesity | 4 |
| Acute Pain | 3 |
| COVID-19 | 3 |
Showing 5 of 128 disease areas.
Trials by start year as sponsor or collaborator (24)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 2 trials are registered to start in 2027 or later, and not listed here.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 4 |
| 2025 | 3 |
| 2024 | 2 |
| 2023 | 5 |
| 2022 | 4 |
| 2021 | 5 |
| 2020 | 6 |
| 2019 | 11 |
| 2018 | 8 |
| 2017 | 5 |
Showing 10 of 24 years.
Prediction, not a registry value: median of 36 months from start to primary completion across 6 trials still running at the 2026-10-09 snapshot; registered median of 23 months across 33 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (25)
Shown in this order: max phase, then active trials.
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| Xylitol | Sinusitis | Phase 2/3 | 1 |
| Xylitol | Rhinosinusitis | Phase 2/3 | 1 |
| RBX7455 | Liver Failure | Phase 2 | 1 |
| RBX7455 | Hepatic Encephalopathy | Phase 2 | 1 |
| RBX7455 | Fibrosis | Phase 2 | 1 |
Showing 5 of 25 active programs.
Approved assets (20)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| Ropivacaine | 2 |
| intravenous NAC | 1 |
| P2Y12 inhibitor | 1 |
| Furosemide plus Chlorothiazide | 1 |
| Exparel Injectable Product | 1 |
Showing 5 of 20 approved assets.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 12% hit target (n=25) | 37% on time (n=19) |
Journals published in (228)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Obstetrics and gynecology | 16 |
| The New England journal of medicine | 13 |
| Anesthesia and analgesia | 12 |
| Journal of the American College of Cardiology | 11 |
| Pain | 10 |
Showing 5 of 228 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 2 | 1 | 2025-12-02 |
Organization relationships (126)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Cincinnati Children's Hospital Medical Center | Co sponsors trial with | 5 |
| University of California System | Co sponsors trial with | 4 |
| The University of Texas System | Co sponsors trial with | 4 |
| Louisiana State University System | Co sponsors trial with | 4 |
| University of Alabama System | Co sponsors trial with | 4 |
Showing 5 of 126 relationships.
Latest dated events (107)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2027-02 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2027-02-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-08-18 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-07-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-06 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 107 events.
Biomarker capability evidence (57)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| ALB | Trial sponsor | Named in trial inclusion criteria |
| ALB | Trial sponsor | Named in trial inclusion criteria |
| ATP7B | Trial collaborator | Named in trial inclusion criteria |
| CLU | Trial sponsor | Named in trial inclusion criteria |
| CRP | Trial collaborator | Named in trial inclusion criteria |
Showing 5 of 57 evidence rows.
On Scientist.com
Ochsner Health System is linked to 2 research suppliers in the Scientist.com network.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarkers this organization publishes on.
Work with Ochsner Clinic Foundation on Scientist.com
For prices, more details, or to contact Ochsner Clinic Foundation, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.